A live-cell ergosterol reporter for visualization of the effects of fluconazole on the human fungal pathogen Candida albicans
mBio · 2023
DOI: 10.1128/mbio.02493-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift mBio, 2023. Verfasst von Antonio Serrano und 3 weiteren Autor:innen. Beteiligte Einrichtung: Université Côte d'Azur, CNRS, INSERM, Institute of Biology Valrose (iBV), Nice, France. Hauptthemen laut MEDLINE: Candida albicans, Ergosterol, Fluconazole, Antifungal Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agence Nationale de la Recherche (ANR), European Commission (EC), EC | European Research Council (ERC).
Abstract (Originalsprache)
Ergosterol, an essential plasma membrane amphipathic lipid, is a major component of the fungal plasma membrane. Most fungal pathogens are susceptible to azole drugs that target ergosterol biosynthesis, and resistance/tolerance to azoles is increasingly problematic. Candida albicans is the most prevalent etiology of candidiasis, and, in this fungal pathogen, ergosterol-rich sub-domains are likely to include sphingolipids, as well as specific membrane proteins, such as multidrug transporters. To investigate the dynamics of ergosterol during the cell cycle and whether drug treatment affects these dynamics in this opportunistic pathogen, we adapted the D4H (domain 4 of the perfringolysin O bacterial toxin) reporter for studying sterol-rich membrane domains. We show that D4H provides a direct readout for the cellular effects of fluconazole and that highly polarized ergosterol is not critical for budding or filamentous growth. IMPORTANCE Ergosterol is a critical membrane lipid in fungi. In Candida albicans , this essential plasma membrane amphipathic lipid is important for interactions with host cells, in particular, host immune responses. Here, we use a live-cell reporter for specifically visualizing ergosterol and show that apical enrichment of this sterol is not critical for budding and filamentous growth in this human fungal pathogen. Our results highlight that this live-cell reporter is likely to be a useful tool in the analyses of azole resistance and tolerance mechanisms, including alterations in drug targets and upregulation of efflux activities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Université Côte d'Azur, CNRS, INSERM, Institute of Biology Valrose (iBV), Nice, France.
ORCID-Profile: Martine Bassilana, Robert A Arkowitz
Förderung
- Agence Nationale de la Recherche (ANR)
- European Commission (EC)
- EC | European Research Council (ERC)
- Centre National de la Recherche Scientifique (CNRS)
- Institut National de la Santé et de la Recherche Médicale (Inserm)
- Université Côte d'Azur (UCA)
Zitieren
APA
Serrano, A., Basante-Bedoya, M. A., Bassilana, M., & Arkowitz, R. A. (2023). A live-cell ergosterol reporter for visualization of the effects of fluconazole on the human fungal pathogen Candida albicans. mBio. https://doi.org/10.1128/mbio.02493-23
Vancouver
Serrano A, Basante-Bedoya MA, Bassilana M, Arkowitz RA. A live-cell ergosterol reporter for visualization of the effects of fluconazole on the human fungal pathogen Candida albicans. mBio. 2023. doi:10.1128/mbio.02493-23
BibTeX
@article{Serrano2023,
author = {Serrano, Antonio and Basante-Bedoya, Miguel A and Bassilana, Martine and Arkowitz, Robert A},
title = {A live-cell ergosterol reporter for visualization of the effects of fluconazole on the human fungal pathogen Candida albicans},
journal = {mBio},
year = {2023},
doi = {10.1128/mbio.02493-23}
}
EUVIMED